https://www.globenewswire.com/news-release/2022/08/15/2498154/18362/en/Latest-Research-Evaluating-VASCEPA-VAZKEPA-icosapent-ethyl-and-Subgroups-from-the-REDUCE-IT-Landmark-Outcomes-Trial-to-be-Presented-at-the-European-Society-of-Cardiology-ESC-Congre.html
0
0
8/15/22 at 12:00pm
Organization
GlobeNewswire
Author
Amarin Corporation plc
50 words
0
Comments
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or...
You are the first to view
Create an account
or login to join the discussion